Memantine hydrochloride is a medication used to treat moderate to severe dementia of the Alzheimer's type [1]. It functions by regulating the activity of glutamate, a neurotransmitter that plays a role in learning and memory [2].
How does memantine work in Alzheimer's?
Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist. In Alzheimer's disease, excessive levels of glutamate can lead to overstimulation of NMDA receptors, causing neuronal damage. Memantine works by blocking these receptors, thereby reducing excitotoxicity and potentially protecting brain cells [2]. It is thought to improve cognitive function and daily living activities in some patients [1].
What are the side effects of memantine?
Common side effects of memantine include dizziness, headache, confusion, constipation, and drowsiness [1]. Less common side effects can include hallucinations, vomiting, and fatigue [1]. Patients should consult their healthcare provider regarding potential side effects and any concerns they may have.
When does memantine's patent expire?
The patent landscape for memantine hydrochloride can be complex, with various patents covering different aspects of the drug, including its formulation and method of use. Information on specific patent expiry dates for memantine and its branded versions can be found through specialized patent databases [3].
Are there generic versions of memantine available?
Yes, generic versions of memantine hydrochloride are available. The availability of generics can impact pricing and accessibility for patients [4].
How does memantine compare to other dementia medications?
Memantine is often prescribed for moderate to severe Alzheimer's, sometimes in combination with acetylcholinesterase inhibitors, which are typically used for mild to moderate stages of the disease [5]. These different classes of drugs target different mechanisms involved in Alzheimer's progression [5].
Sources:
[1] https://www.nhs.uk/medicine-guides/pages/medicine-discussions.aspx?medicine=MEMANTINE
[2] https://www.alzheimers.org.uk/about-dementia/treatments/memantine
[3] https://drugpatentwatch.com/
[4] https://www.goodrx.com/memantine
[5] https://www.nia.nih.gov/health/alzheimers-dementia-care-and-support/treatment-dementia-care